XML 17 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 447,967 $ 499,919
Short term investment 17,242
Other receivable 12,842 41,516
Total current assets 460,809 558,677
Total assets 460,809 558,677
Current liabilities:    
Accounts payable and accrued liabilities 98,871 13,115
Accounts payable interest payable 8,227
Employee payable 7,064
Short term portion of convertible notes (Note 2) 503,217 485,449
Liabilities held for sale 469,525 469,525
Total current liabilities 1,079,840 975,153
Total liabilities 1,079,840 975,153
Stockholders' deficit    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; none issued and outstanding at March 2019
Common stock, $0.0001 par value; 490,000,000 shares authorized; 110,748,391 shares issued and outstanding at March 31, 2019 and December 31, 2018. (Note 3) 11,075 11,075
Accumulated other comprehensive income (19,337) (19,337)
Additional paid-in capital (Note 3) 41,100,794 41,218,691
Accumulated deficit (41,711,563) (41,626,905)
Total stockholders' deficit (619,031) (416,476)
Total liabilities and stockholders' deficit $ 460,809 $ 558,677